Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 2 |
2021 | 2 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Comparing the efficacy of pulsed dye laser, Q-Switched Nd-YAG, CO2, and combined CO(2) and Q-Switched Nd-YAG lasers for the treatment of cutaneous macular amyloidosis.
J Dermatolog Treat. 2021 Mar;32(2):258-260. doi: 10.1080/09546634.2019.1654071. Epub 2019 Aug 25.
J Dermatolog Treat. 2021.
PMID: 31415215
BACKGROUND: No topical and systemic treatment is proven to be effective on Cutaneous Macular Amyloidosis (CMA). The physical removal of the deposited protein by lasers may be a better choice. OBJECTIVE: To compare the efficacy of different lasers including Pu …
BACKGROUND: No topical and systemic treatment is proven to be effective on Cutaneous Macular Amyloidosis (CMA). The phy …
Comparative study of fractional CO2 laser and fractional CO2 laser-assisted drug delivery of topical steroid and topical vitamin C in macular amyloidosis.
Sobhi RM, Sharaoui I, El Nabarawy EA, El Nemr Esmail RS, Hegazy RA, Aref DHF.
Sobhi RM, et al.
Lasers Med Sci. 2018 May;33(4):909-916. doi: 10.1007/s10103-018-2457-1. Epub 2018 Feb 26.
Lasers Med Sci. 2018.
PMID: 29480422
To determine the effect of fractional CO(2) laser in macular amyloidosis in comparison to fractional CO(2) laser-assisted drug delivery of topical steroids and topical vitamin C, the study includes 10 female patients with cutaneous macular amyloidosis aged be …
To determine the effect of fractional CO(2) laser in macular amyloidosis in comparison to fractional CO(2) laser-assisted drug delivery of t …
Item in Clipboard
The therapeutic effects of 1540-nm nonablative fractional erbium laser on macular amyloidosis: a randomized clinical trial.
Nahidi Y, Delghandi SR, Kiafar B, Saki A.
Nahidi Y, et al.
J Dermatolog Treat. 2021 May;32(3):340-344. doi: 10.1080/09546634.2019.1655136. Epub 2019 Aug 29.
J Dermatolog Treat. 2021.
PMID: 31411528
Clinical Trial.
OBJECTIVE: This aim of this study was to determine the effect of 1540-nm nonablative fractional erbium on macular amyloidosis. METHODS: This phase-II clinical trial study has been performed with parallel group with blinding of the evaluator. The skin lesions of the …
OBJECTIVE: This aim of this study was to determine the effect of 1540-nm nonablative fractional erbium on macular amyloidosis. METHODS: This …
Item in Clipboard
Efficacy of topical gabapentin in women with primary macular amyloidosis: A side-by-side triple-blinded randomized clinical trial.
Abtahi-Naeini B, Hemati E, Faghihi G, Shahmoradi Z, Paknazar F, Rastegarnasab F, Varshosaz J, Hadian M, Akbari M, Sabzghabaee AM.
Abtahi-Naeini B, et al.
J Cosmet Dermatol. 2024 May;23(5):1677-1684. doi: 10.1111/jocd.16180. Epub 2024 Jan 30.
J Cosmet Dermatol. 2024.
PMID: 38291677
Clinical Trial.
BACKGROUND: Primary cutaneous macular amyloidosis (PCMA) is a chronic pruritic cutaneous disease characterized by heterogeneous extracellular deposition of amyloid protein in the skin. AIMS: This study aimed to evaluate the efficacy of topical 6% gabapentin c …
BACKGROUND: Primary cutaneous macular amyloidosis (PCMA) is a chronic pruritic cutaneous disease characterized by heter …
Item in Clipboard
Cite
Cite